RE:RE:Experts having hissy fits Actually the problem was that biogen and FDA were the only ones who had access to the the additional info and thats helped the FDA makes their decision. Alot of the upper management and scientists at PMN and some of these other companies knew there was more data that others were not seeing ( including them), and were pretty sure that if FDA approved Biogen there were going to be way more conditions .. but to their surprize .. very limited conditions. Big bonus for the science of amyloids.